Mabion S.A.

Warsaw Stock Exchange:MAB.WA

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

Poland

Market Cap

USD 42.87 M

Share Price

USD 2.65

Avg Daily Volume

42,990

Change (1 day)

1.43%

Change (1 year)

-36.02%

Change (YTD)

22.69%

Mabion S.A. Share Price Year-To-Date (YTD) return on June 23, 2025: 22.69%

Mabion S.A. Share Price Year-To-Date (YTD) return is 22.69% on June 23, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Mabion S.A. 52-week low Share Price is USD 4.99 on June 23, 2025, which is 88.30% above the current Share Price.
Mabion S.A. 52-week low Share Price is USD 2.06 on June 23, 2025, which is -22.31% below the current Share Price.
Mabion S.A. average Share Price for the last 52 weeks is USD 3.24.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Warsaw Stock Exchange: MAB.WA

Mabion S.A.

CEO	Mr. Krzysztof Kaczmarczyk
IPO Date	Aug. 10, 2010
Location	Poland
Headquarters	ul. gen. Mariana Langiewicza 60
Employees	206
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies

Description

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.